Pyridine-2-sulfonic Acid
CAS:15103-48-7
Formula:
C5H5NO3S
Purity:
>98.0%(T)(HPLC)
Color and Shape:
White to Light yellow powder to crystal
Molecular weight:
159.16
Ref: 3B-P1647
5g | 104.00 € | ||
25g | 317.00 € |
Estimated delivery in United States, on Thursday 9 Jan 2025
2-Pyridinesulfonic acid, 97%
CAS:15103-48-7
This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. …
Formula:
C5H5NO3S
Purity:
97%
Color and Shape:
White to tan, Crystalline powder and/or chunks
Molecular weight:
159.16
Ref: AC-45576
5g | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
2-Pyridinesulfonic acid
CAS:15103-48-7
Formula:
C5H5NO3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
159.1631
Ref: IN-DA001N1E
1g | 32.00 € | ||
5g | 75.00 € | ||
10g | 115.00 € | ||
25g | 195.00 € | ||
250mg | 24.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Pyridine-2-sulphonic acid
CAS:15103-48-7
Formula:
C5H5NO3S
Purity:
98%
Color and Shape:
white solid
Molecular weight:
159.16g/mol
Ref: 54-OR5272
5g | 102.00 € | ||
25g | 352.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
Pyridine-2-sulphonic acid
CAS:15103-48-7
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
159.16000366210938
Ref: 10-F434335
1g | To inquire | ||
5g | 56.00 € | ||
10g | 101.00 € | ||
25g | 211.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Pyridine-2-sulfonicacid
CAS:15103-48-7
Pyridine-2-sulfonicacid is a sulfonate salt with an inhibitory effect on cancer cells. It is a …
Formula:
C5H5NO3S
Purity:
Min. 95%
Molecular weight:
159.16 g/mol
Ref: 3D-FP149086
2g | To inquire | ||
5g | To inquire | ||
10g | To inquire | ||
25g | To inquire | ||
50g | To inquire |
Estimated delivery in United States, on Thursday 27 Feb 2025
2-Pyridinesulfonic Acid
CAS:15103-48-7
Formula:
C5H5NO3S
Color and Shape:
White Solid
Molecular weight:
96.13
Ref: TR-P991460
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
25g | Discontinued | Request information |